Download PDF
Krankenhaushygiene up2date 2012; 07(03): 183-197
DOI: 10.1055/s-0032-1310284
Antibiotikaanwendung
© Georg Thieme Verlag KG Stuttgart · New York

Rationale Antibiotikatherapie in der ambulanten medizinischen Versorgung

Janine Zweigner
,
Frank Schwab
,
Petra Gastmeier
Further Information

Publication History

Publication Date:
10 September 2012 (online)

Also available at
    Permissions and Reprints All articles of this category

Kernaussagen

In Deutschland werden für die Behandlung von Patienten ca. 85 % aller Antibiotika in der ambulanten medizinischen Versorgung verschrieben und nur ca. 15 % in den Krankenhäusern. Schätzungen gehen davon aus, dass ca. 50 % der Antibiotikaverordnungen unnötig oder inadäquat sind. Die häufigsten Infektionen, die ambulant diagnostiziert werden, sind Infektionen der oberen Atemwege und Harnwegsinfektionen. Mehr als 80 % der Atemwegsinfektionen wie die sog. grippalen Infekte oder die Bronchitis werden viral verursacht, wogegen Antibiotika unwirksam sind. Immer häufiger werden in Deutschland in der ambulanten Versorgung Antibiotika eingesetzt mit einem sehr breiten Wirkungsspektrum wie Chinolone, Dritt- und Viertgenerations-Cephalosporine und Makrolide, was zu einem Selektionsdruck und zunehmender Resistenzentwicklung gegenüber diesen Antibiotika führt. Der Einsatz von „Biomarkern“ wie Procalcitonin und C-reaktives Protein sowie multimodale Schulungen zum rationalen Einsatz von Antibiotika und die Aufklärung der Patienten können dazu beitragen, die Wirksamkeit der verfügbaren Antibiotika möglichst lange zu erhalten.

 

  • Literatur

  • 1 (EMA) ECfDPaICEatEMA. ECDC/EMA Joint Technical Report 2009: The bacterial challenge- time to react. Im Internet: http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf Stand: August 2012
  • 2 (BVL) BfVuL. GERMAP 2010 – Antibiotika-Resistenz und -Verbrauch. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Im Internet: http://www.p-e-g.org/econtext/germap Stand: August 2012
  • 3 (BVL) BfVuL. GERMAP 2008 – Antibiotika-Resistenz und -Verbrauch. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Im Internet: http://www.bvl.bund.de/SharedDocs/Downloads/08_PresseInfothek/Germap_2008.html?nn=1461380 Stand: August 2012
  • 4 De With KSH, Meyer E, Nink K et al. Antibiotikaanwendung in Deutschland im europäischen Vergleich. Dtsch Med Wochenschr 2004; 129: 1987-1992
    Thieme ConnectSearch in Google Scholar
  • 5 Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother 2011; 66 (Suppl. 06) vi3-12
    CrossrefSearch in Google Scholar
  • 6 ECDC. Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. Im Internet: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=767 Stand: August 2012
  • 7 Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-587
    CrossrefPubMedSearch in Google Scholar
  • 8 Schröder H, Nink K, Günther J et al. Antibiotika: Solange sie noch wirken. GGW 2003; 3: 7-16
    Search in Google Scholar
  • 9 Günther J, Kern WV, Nink K et al. Solange sie noch wirken...Analyse und Kommentare zum Antbiotikaverbrauch in Deutschland. Bonn und Freiburg: Wissenschaftliches Institut der AOK (WIdo)/Universität Freiburg; 2010
    Search in Google Scholar
  • 10 Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother 2011; 66 (Suppl. 06) vi71-77
    CrossrefSearch in Google Scholar
  • 11 Goossens H, Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997–2004). Diagn Microbiol Infect Dis 2005; 53: 257-264
    CrossrefSearch in Google Scholar
  • 12 Aldeyab MA, Harbarth S, Vernaz N et al. The impact of antibiotic use on the incidence and resistance pattern of ESBL-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 2011;
    Search in Google Scholar
  • 13 File Jr TM, Hadley JA. Rational use of antibiotics to treat respiratory tract infections. Am J Managed Care 2002; 8: 713-727
    Search in Google Scholar
  • 14 Cooper RJ, Hoffman JR, Bartlett JG et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emergency Med 2001; 37: 711-719
    CrossrefSearch in Google Scholar
  • 15 S3-Leitlinie der Paul-Ehrlich-Gesellschaft für Chemotherapie dDGfPuB, der Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ. Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009. Pneumologie 2009; 63: e1-e68
    Thieme ConnectSearch in Google Scholar
  • 16 Johnston SL, Blasi F, Black PN et al. The effect of telithromycin in acute exacerbations of asthma. N Eng J Med 2006; 354: 1589-1600
    CrossrefSearch in Google Scholar
  • 17 van Driel ML, De Sutter AI, Keber N et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev 2010;
    Search in Google Scholar
  • 18 von Baum H, Welte T, Marre R et al. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009; 9: 62
    CrossrefSearch in Google Scholar
  • 19 Wellinghausen N, Straube E, Freidank H et al. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol 2006; 296: 485-491
    CrossrefSearch in Google Scholar
  • 20 Welte TMR, Suttorp N. What is new in the treatment of community acquired pneumonia?. Med Klin (Munich) 2006; 101: 313-320
    CrossrefSearch in Google Scholar
  • 21 Wagenlehner FM, Schmiemann G, Hoyme U et al. [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients]. Der Urologe, Ausg A 2011; 50: 153-169
    CrossrefSearch in Google Scholar
  • 22 Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607
    CrossrefSearch in Google Scholar
  • 23 Muller B, Becker KL, Schachinger H et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28: 977-983
    CrossrefSearch in Google Scholar
  • 24 Müller B, Schuetz P, Christ-Crain M. Procalcitonin. Schweizer Medizin-Forum 2008; 8: 388-390
    Search in Google Scholar
  • 25 Stolz D, Christ-Crain M, Bingisser R et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007; 131: 9-19
    CrossrefSearch in Google Scholar
  • 26 Briel M, Schuetz P, Mueller B et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Internal Med 2008; 168: 2000-2007 discussion 2007-2008
    CrossrefSearch in Google Scholar
  • 27 Burkhardt O, Ewig S, Haagen U et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J 2010; 36: 601-607
    CrossrefSearch in Google Scholar
  • 28 Schuetz P, Chiappa V, Briel M et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Internal Med 2011; 171: 1322-1331
    CrossrefSearch in Google Scholar
  • 29 Diederichsen HZ, Skamling M, Diederichsen A et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Primary Health Care 2000; 18: 39-43
    CrossrefSearch in Google Scholar
  • 30 Dahler-Eriksen BS, Lauritzen T, Lassen JF et al. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem 1999; 45: 478-485
    Search in Google Scholar
  • 31 Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004; 54: 659-662
    Search in Google Scholar
  • 32 Hansen JG, Schmidt H, Grinsted P. Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scand J Prim Health Care 2000; 18: 44-47
    CrossrefSearch in Google Scholar
  • 33 Bjerrum L, Cots JM, Llor C et al. Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: a prospective, before and after study in general practice. Eur J Clin Pharmacol 2006; 62: 913-918
    CrossrefSearch in Google Scholar
  • 34 Arnold SR, Straus S. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews 2009; 1-79
    Search in Google Scholar
  • 35 Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement.. J Amer Med Assoc 1999; 282: 1458-1465
    CrossrefSearch in Google Scholar
  • 36 André M, Vernby Å, Berg J et al. A survey of public knowledge and awareness related to antibiotic use and resistance in Sweden. Journal Antimicrob Chemother 2010; 65: 1292-1296
    Search in Google Scholar
  • 37 Bjerrum L, Munck A, Gahrn-Hansen B et al. Health alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT) – impact of a non-randomised multifaceted intervention programme. BMC Family Pract 2011; 12: 52
    Search in Google Scholar
  • 38 Butler CC, Simpson SA, Dunstan F et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. Br Med J 2012; 344: d8173
    CrossrefSearch in Google Scholar
  • 39 Altiner A, Brockmann S, Sielk M et al. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. Journal Antimicrob Chemother 2007; 60: 638-644
    Search in Google Scholar
  • 40 Faber MS, Heckenbach K, Velasco E et al. Antibiotics for the common cold: expectations of Germany’s general population. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2010: 15
    Search in Google Scholar
  • 41 Velasco E, Espelage W, Faber M et al. A national cross-sectional study on socio-behavioural factors that influence physicians’ decisions to begin antimicrobial therapy. Infection 2011; 39: 289-297
    CrossrefSearch in Google Scholar
  • 42 Velasco E, Ziegelmann A, Eckmanns T et al. Eliciting views on antibiotic prescribing and resistance among hospital and outpatient care physicians in Berlin, Germany: results of a qualitative study. Br Med J open 2012; 2 e000398
    Search in Google Scholar
  • 43 Weber JT, Courvalin P. An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis 2005; 11: 791-793
    CrossrefSearch in Google Scholar
  • 44 Levy-Hara G, Amábile-Cuevas CF, Gould I et al. on behalf of the International Society of Chemotherapy Antimicrobial Stewardship Working Group. „Ten Commandments“ for the appropriate use of antibiotics by the practicing physician in an outpatient setting. Front Microbiol 2011; 2: 1-7
    Search in Google Scholar